Clinical pharmacogenetic testing and application: Laboratory medicine clinical practice guidelines

Sollip Kim, Yeo Min Yun, Hyo Jin Chae, Hyun Jung Cho, Misuk Ji, In Suk Kim, Kyung A. Wee, Woochang Lee, Sang Hoon Song, Hye In Woo, Soo Youn Lee, Sail Chun

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.

Original languageEnglish
Pages (from-to)180-193
Number of pages14
JournalAnnals of laboratory medicine
Volume37
Issue number2
DOIs
Publication statusPublished - 2017 Mar

Fingerprint

Clinical Medicine
Practice Guidelines
Medicine
Testing
Pharmacogenetics
Expert Testimony
Korea
Insurance
Guidelines
Costs and Cost Analysis
Pharmacogenomic Testing
Costs

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Kim, Sollip ; Yun, Yeo Min ; Chae, Hyo Jin ; Cho, Hyun Jung ; Ji, Misuk ; Kim, In Suk ; Wee, Kyung A. ; Lee, Woochang ; Song, Sang Hoon ; Woo, Hye In ; Lee, Soo Youn ; Chun, Sail. / Clinical pharmacogenetic testing and application : Laboratory medicine clinical practice guidelines. In: Annals of laboratory medicine. 2017 ; Vol. 37, No. 2. pp. 180-193.
@article{b915deec321a42cc8ad61c7c067b76ba,
title = "Clinical pharmacogenetic testing and application: Laboratory medicine clinical practice guidelines",
abstract = "Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.",
author = "Sollip Kim and Yun, {Yeo Min} and Chae, {Hyo Jin} and Cho, {Hyun Jung} and Misuk Ji and Kim, {In Suk} and Wee, {Kyung A.} and Woochang Lee and Song, {Sang Hoon} and Woo, {Hye In} and Lee, {Soo Youn} and Sail Chun",
year = "2017",
month = "3",
doi = "10.3343/alm.2017.37.2.180",
language = "English",
volume = "37",
pages = "180--193",
journal = "Annals of Laboratory Medicine",
issn = "2234-3806",
publisher = "Seoul National University",
number = "2",

}

Kim, S, Yun, YM, Chae, HJ, Cho, HJ, Ji, M, Kim, IS, Wee, KA, Lee, W, Song, SH, Woo, HI, Lee, SY & Chun, S 2017, 'Clinical pharmacogenetic testing and application: Laboratory medicine clinical practice guidelines', Annals of laboratory medicine, vol. 37, no. 2, pp. 180-193. https://doi.org/10.3343/alm.2017.37.2.180

Clinical pharmacogenetic testing and application : Laboratory medicine clinical practice guidelines. / Kim, Sollip; Yun, Yeo Min; Chae, Hyo Jin; Cho, Hyun Jung; Ji, Misuk; Kim, In Suk; Wee, Kyung A.; Lee, Woochang; Song, Sang Hoon; Woo, Hye In; Lee, Soo Youn; Chun, Sail.

In: Annals of laboratory medicine, Vol. 37, No. 2, 03.2017, p. 180-193.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical pharmacogenetic testing and application

T2 - Laboratory medicine clinical practice guidelines

AU - Kim, Sollip

AU - Yun, Yeo Min

AU - Chae, Hyo Jin

AU - Cho, Hyun Jung

AU - Ji, Misuk

AU - Kim, In Suk

AU - Wee, Kyung A.

AU - Lee, Woochang

AU - Song, Sang Hoon

AU - Woo, Hye In

AU - Lee, Soo Youn

AU - Chun, Sail

PY - 2017/3

Y1 - 2017/3

N2 - Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.

AB - Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.

UR - http://www.scopus.com/inward/record.url?scp=85011395280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011395280&partnerID=8YFLogxK

U2 - 10.3343/alm.2017.37.2.180

DO - 10.3343/alm.2017.37.2.180

M3 - Article

C2 - 28029011

AN - SCOPUS:85011395280

VL - 37

SP - 180

EP - 193

JO - Annals of Laboratory Medicine

JF - Annals of Laboratory Medicine

SN - 2234-3806

IS - 2

ER -